Disease Surveillance for Haemophilus Ducreyi
At present, there are indeed active surveillance systems to monitor the prevalence and reemergence of H. Ducreyi both in United States. This is despite the increased diminishing of the disease on the U.S global scale. There are various surveillance systems for H. ducreyi and which include laboratory reports, which should be reported to the National Department of Health as soon as the condition is discovered. In U.S, the specific lab test for H. ducreyi is No FDA-cleared PCR test, which can also be undertaken by clinical laboratories, especially those that have put in place their PCR test as well as performed a Clinical Laboratory Improvement Amendment(CLIA) verification (Center for Disease Control and Prevention, 2011). Further, many public and private hospitals in U.S for instance, harbor a document identified as a STD Confidential Case Report Form where healthcare practitioners are required to use it in reporting the condition. What is more, a number of states have also toll free numbers which patients and health practitioners can use in directly reporting the disease should they notice its occurrence (Minnesota Health Department, 2015).
Despite the decline of H. ducreyi in U.S perspective, the surveillance and monitoring systems are still emphasized because of the sporadic nature of the disease once it occurs. In other words, its outbreak is spontaneous and can be transmitted to many other people once it occurs. Further, despite its continued diminishing, the disease has still a potential of causing infection to many people. In addition, it presents high transmission of HIV infection (CDC, 2011). Once the prevalence of this condition has been made, specific actions are then made by the relevant stakeholders including follow up to curb the phenomena. Therefore, it can be rightly be said that the surveillance and monitoring systems for H.ducrey is active.